CellScape

company

About

CellScape Corporation is focused on developing a comprehensive non-invasive prenatal genetic test for women.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$1.60M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

CellScape Corporation (formerly Saryna Medical Corp) is a privately funded company headquartered in Newark, California, in the heart of the biotech corridor of the San Francisco Bay Area. The Company has developed whole fetal cell technology to transform prenatal genetic testing using a simple blood test. Their vision is to make comprehensive prenatal genetic testing available to every woman without requiring an invasive procedure that might put the fetus at risk. Their leadership team is accomplished in bringing innovative, cost-effective medical and molecular diagnostics to market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$10.90M
CellScape has raised a total of $10.90M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2012 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2012 Series B $9.30M 1 Detail
Dec 1, 2010 Series A $1.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CellScape is funded by 1 investors. Zygote Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Zygote Ventures Series B